跳至主要内容
临床试验/IRCT20201003048912N2
IRCT20201003048912N2招募中3 期

Effect of Growth Hormone on Improve Pregnancy Rate in Women with poor ovarian response

Avicenna University Jihad Infertility Center Avicenna0 个研究点目标入组 124 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
124

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20 years 至 40 years(—)
性别
Female

入选标准

  • Age less than 40 years,
  • Normal karyotype,
  • Normal thrombophilia (having two or less than two positive tests for thrombophilic heterozygotes)
  • Formation of 5 embryos (more than 3 embryos with good quality)
  • Patients with poor ovarian response (history of an ovulation stimulation cycle with less than 4 oocytes and AMH <1.1 and FSH <20) in infertile women referred to Ibn Sina Infertility Treatment Center

排除标准

  • Endometriosis disease
  • Severe oligospermia (morphology count <1%)
  • Patients with hydrosalpinx
  • History of ovarian surgery
  • Underlying disease such as kidney and liver and diabetes and thyroid autoimmune
  • Allergic local reactions and benign increase in intracranial pressure

研究者

发起方
Avicenna University Jihad Infertility Center Avicenna

相似试验

招募中
3 期
The effect of growth hormone on increasing pregnancy success rate in women with unexplained recurrent implantation failure: A multicenter clinical randomized study.Condition 1: Patients with recurrent implantation failure. Condition 2: Patients with recurrent implantation failure.Complications of attempted introduction of fertilized ovum following in vitro fertilizationFemale infertility of uterine originN98.2N97.2
IRCT20201003048912N1Avicenna Reseacrh Institute356
已完成
不适用
The effects of growth hormone (GH) on the results of echocardiography in patients with heart failure (HF) four weeks after myocardial infarction (MI)
IRCT201704083035N1Vice chancellor for research, School of Medicine, Isfahan University of Medical Sciences32
招募中
2 期
Effect of Gh on pregnancy outcome in RIFInfertility.Female infertility of other originN97.8
IRCT20091012002576N34Tehran University of Medical Sciences60
进行中(未招募)
不适用
Can treatment with human growth hormone increase strength in spinal muscular atrophy type II and III? - SMA-GHSpinal muscular atrophy (SMA) is an autosomal recessive disease. Due to the genetic defect, a molecule called spinal motor neuron” (SMN) protein is lacking, resulting in muscle weakness. In SMAs muscle weakness is found most often at the level of proximal muscles. The disease is life-threatening and chronically debilitating.
EUCTR2005-002822-78-DEKlinik Neuropädiatrie und Muskelkrankheiten20
已完成
不适用
Growth hormone deficiency and clotting
ISRCTN59234325eeds Teaching Hospitals NHS Trust (UK)140